Merck
Damien Jullie is a Senior Scientist II at Merck since October 2022, leading programs in target validation and in vitro assay development, following a tenure as Senior Scientist focused on high content microscopy assay development. Prior to Merck, Damien Jullie was a Postdoctoral Fellow at UCSF from October 2013 to October 2022. Education includes a PhD in Neuroscience from Université de Bordeaux (2008-2012), a Master 2 in Neurobiologie et neurosciences from Ecole normale supérieure (2005-2008), as well as earlier studies as a Master 1 student at Université de Montréal and a Master 2 student at Institut Cochin.
This person is not in any offices
Merck
282 followers
Merck is a global healthcare leader working to help the world be well. Merck is known as MSD outside the United States and Canada.